(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 19.24%13.21B | 18.28%8.59B | 23.05%4.28B | -19.18%15.59B | -26.89%11.07B | -32.76%7.26B | -34.84%3.48B | -14.44%19.29B | -9.20%15.15B | -2.15%10.79B |
Operating income | 19.24%13.21B | 18.28%8.59B | 23.05%4.28B | -19.18%15.59B | -26.89%11.07B | -32.76%7.26B | -34.84%3.48B | -14.44%19.29B | -9.20%15.15B | -2.15%10.79B |
Cost of sales | ---- | -19.55%-7.89B | ---- | 19.87%-14.27B | ---- | 32.15%-6.6B | ---- | 10.68%-17.8B | ---- | -0.14%-9.72B |
Operating expenses | -19.55%-7.89B | 19.87%-14.27B | 32.15%-6.6B | 10.68%-17.8B | -0.14%-9.72B | |||||
Gross profit | 5.61%697.38M | -10.96%1.32B | -38.28%660.32M | -43.17%1.48B | -19.01%1.07B | |||||
Selling expenses | ---- | 14.39%-154.22M | ---- | 29.88%-321.29M | ---- | 22.30%-180.15M | ---- | -4.78%-458.22M | ---- | -2.89%-231.83M |
Administrative expenses | ---- | -10.93%-242.37M | ---- | 23.09%-449.02M | ---- | 8.23%-218.49M | ---- | -20.09%-583.79M | ---- | -21.96%-238.09M |
Revaluation surplus | ---- | 5,286.52%7.6M | ---- | ---- | ---- | 112.70%141K | ---- | ---- | ---- | 68.99%-1.11M |
-Changes in the fair value of financial assets | ---- | 5,286.52%7.6M | ---- | ---- | ---- | 112.70%141K | ---- | ---- | ---- | 68.99%-1.11M |
Impairment and provision | ---- | ---- | ---- | -243.41%-51.25M | ---- | ---- | ---- | 127.16%35.74M | ---- | ---- |
-Goodwill impairment | ---- | ---- | ---- | ---53.42M | ---- | ---- | ---- | ---- | ---- | ---- |
-Other impairment is provision | ---- | ---- | ---- | -93.93%2.17M | ---- | ---- | ---- | 172.29%35.74M | ---- | ---- |
Operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 5.07%-176.38M |
Special items of operating profit | ---- | -52.15%63.33M | ---- | -61.01%91.3M | ---- | -30.74%132.35M | ---- | -15.49%234.16M | ---- | 58.79%191.1M |
Operating profit | -5.70%371.71M | -16.95%592.03M | -35.76%394.18M | -52.28%712.87M | -26.20%613.59M | |||||
Financing cost | ---- | -0.68%-193.06M | ---- | -9.84%-389.44M | ---- | ---191.76M | ---- | ---354.56M | ---- | ---- |
Share of profits of associates | ---- | 42.06%-23.97M | ---- | 156.37%46.8M | ---- | -740.37%-41.37M | ---- | -82.11%18.26M | ---- | -87.08%6.46M |
Earning before tax | -3.96%154.68M | -33.77%249.39M | -74.03%161.06M | -76.40%376.57M | -29.66%620.05M | |||||
Tax | ---- | 11.74%-26.8M | ---- | -55.06%-88.95M | ---- | 67.01%-30.36M | ---- | 65.28%-57.36M | ---- | 41.56%-92.04M |
After-tax profit from continuing operations | -2.15%127.88M | -49.74%160.44M | -75.25%130.69M | -77.69%319.2M | -27.07%528.01M | |||||
Earning after tax | -2.15%127.88M | -49.74%160.44M | -75.25%130.69M | -77.69%319.2M | -27.07%528.01M | |||||
Minority profit | ---- | -25.44%-46.27M | ---- | -10,674.69%-102.36M | ---- | -13.82%-36.89M | ---- | -98.16%968K | ---- | -155.39%-32.41M |
Profit attributable to shareholders | 3.92%174.15M | -17.42%262.8M | -70.10%167.58M | -76.91%318.23M | -15.79%560.42M | |||||
Basic earnings per share | 3.96%0.0551 | -14.94%0.0831 | -68.91%0.053 | -76.68%0.0977 | -15.72%0.1705 | |||||
Diluted earnings per share | ||||||||||
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | -- | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data